Upregulation of Sox9 (by qPCR) in HCC was associated with poorer tumor cell differentiation (p = 0.003), venous invasion (p = 0.026), higher tumor stage (p = 0.044) and shorter overall survival (Table 1 and Figure 1C). This evidence concerns the gene SOX9 and hepatocellular carcinoma.